NL7305097A - - Google Patents

Info

Publication number
NL7305097A
NL7305097A NL7305097A NL7305097A NL7305097A NL 7305097 A NL7305097 A NL 7305097A NL 7305097 A NL7305097 A NL 7305097A NL 7305097 A NL7305097 A NL 7305097A NL 7305097 A NL7305097 A NL 7305097A
Authority
NL
Netherlands
Application number
NL7305097A
Other versions
NL174459B (nl
NL174459C (nl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22918877&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NL7305097(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of NL7305097A publication Critical patent/NL7305097A/xx
Publication of NL174459B publication Critical patent/NL174459B/xx
Application granted granted Critical
Publication of NL174459C publication Critical patent/NL174459C/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/46—Friedel-Crafts reactions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NLAANVRAGE7305097,A 1972-04-12 1973-04-11 Werkwijze ter bereiding van geneesmiddelen geschikt voor de behandeling van acuut verlaagd contractie-vermogen van het hart, alsmede werkwijze ter bereiding van geneeskrachtige verbindingen geschikt voor toepassing hierbij. NL174459C (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24346672A 1972-04-12 1972-04-12

Publications (3)

Publication Number Publication Date
NL7305097A true NL7305097A (cg-RX-API-DMAC7.html) 1973-10-16
NL174459B NL174459B (nl) 1984-01-16
NL174459C NL174459C (nl) 1984-06-18

Family

ID=22918877

Family Applications (1)

Application Number Title Priority Date Filing Date
NLAANVRAGE7305097,A NL174459C (nl) 1972-04-12 1973-04-11 Werkwijze ter bereiding van geneesmiddelen geschikt voor de behandeling van acuut verlaagd contractie-vermogen van het hart, alsmede werkwijze ter bereiding van geneeskrachtige verbindingen geschikt voor toepassing hierbij.

Country Status (31)

Country Link
JP (2) JPS5825656B2 (cg-RX-API-DMAC7.html)
KR (1) KR790000113B1 (cg-RX-API-DMAC7.html)
AR (1) AR203822A1 (cg-RX-API-DMAC7.html)
AT (1) AT323719B (cg-RX-API-DMAC7.html)
AU (1) AU472734B2 (cg-RX-API-DMAC7.html)
BE (1) BE798051A (cg-RX-API-DMAC7.html)
BG (1) BG23001A3 (cg-RX-API-DMAC7.html)
CA (1) CA1018188A (cg-RX-API-DMAC7.html)
CH (2) CH569691A5 (cg-RX-API-DMAC7.html)
CS (2) CS190406B2 (cg-RX-API-DMAC7.html)
CY (1) CY963A (cg-RX-API-DMAC7.html)
DD (1) DD107670B3 (cg-RX-API-DMAC7.html)
DE (1) DE2317710C2 (cg-RX-API-DMAC7.html)
DK (1) DK142750C (cg-RX-API-DMAC7.html)
ES (1) ES413639A1 (cg-RX-API-DMAC7.html)
FR (1) FR2182947B1 (cg-RX-API-DMAC7.html)
GB (1) GB1392674A (cg-RX-API-DMAC7.html)
HK (1) HK50178A (cg-RX-API-DMAC7.html)
HU (2) HU166213B (cg-RX-API-DMAC7.html)
IE (1) IE37511B1 (cg-RX-API-DMAC7.html)
IL (1) IL42016A (cg-RX-API-DMAC7.html)
KE (1) KE2870A (cg-RX-API-DMAC7.html)
MY (1) MY7800381A (cg-RX-API-DMAC7.html)
NL (1) NL174459C (cg-RX-API-DMAC7.html)
PH (1) PH11041A (cg-RX-API-DMAC7.html)
PL (2) PL90695B1 (cg-RX-API-DMAC7.html)
RO (2) RO70892A (cg-RX-API-DMAC7.html)
SE (1) SE399064B (cg-RX-API-DMAC7.html)
SU (1) SU496719A3 (cg-RX-API-DMAC7.html)
YU (2) YU36483B (cg-RX-API-DMAC7.html)
ZA (1) ZA732136B (cg-RX-API-DMAC7.html)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH585693A5 (cg-RX-API-DMAC7.html) * 1974-02-08 1977-03-15 Ciba Geigy Ag
US4342692A (en) * 1980-10-20 1982-08-03 Usv Pharmaceutical Corporation Pyrrolidines
ZA825227B (en) * 1981-07-22 1984-03-28 Syntex Inc Substituted pyrrolidine cardiovascular system regulators antihypertensives
JPS6061523A (ja) * 1983-09-16 1985-04-09 Shionogi & Co Ltd 経口用ドブタミン製剤
IL85438A0 (en) * 1987-02-24 1988-07-31 Lilly Co Eli Improvements in or relating to dobutamine salts
JPH0383364U (cg-RX-API-DMAC7.html) * 1989-12-18 1991-08-23
WO1992020645A1 (en) * 1991-05-20 1992-11-26 Tsumura & Co. Phellodendrine analogs and allergy type iv suppressor containing the same as active ingredient
EP0620208B1 (en) * 1993-04-13 1997-07-09 Duphar International Research B.V Production of dobutamine compounds
ATE155125T1 (de) * 1993-04-13 1997-07-15 Duphar Int Res Herstellung von dobutamin verbindungen
US7642290B2 (en) 2002-10-03 2010-01-05 Novaremed Limited Compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection
US7674829B2 (en) 2004-03-26 2010-03-09 Novaremed Limited Compounds for the treatment of AIDS and other viral diseases
GB0804213D0 (en) 2008-03-06 2008-04-16 New Era Biotech Ltd A method of printing or preventing pain
RU2012107457A (ru) 2009-07-31 2013-09-10 Когнишн Терапьютикс, Инк. Ингибиторы ухудшения когнитивных способностей
US8802734B2 (en) 2009-09-09 2014-08-12 Novaremed Limited Method of treating or preventing pain
WO2013029057A2 (en) * 2011-08-25 2013-02-28 Cognition Therapeutics, Inc. Compositions and methods for treating neurodegenerative disease
WO2015116923A1 (en) 2014-01-31 2015-08-06 Cognition Therapeutics, Inc. Isoindoline compositions and methods for treating neurodegenerative disease
ES3063712T3 (en) 2017-05-15 2026-04-20 Cognition Therapeutics Inc Compositions for treating neurodegenerative diseases
CN114524734B (zh) * 2021-12-27 2024-04-26 嘉实（湖南）医药科技有限公司 一种盐酸多巴酚丁胺的制备方法
CN117326958B (zh) * 2023-09-21 2025-07-11 锦州奥鸿药业有限责任公司 一种高纯度盐酸多巴酚丁胺的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2276619A (en) * 1942-03-17 N-phentlaliphatic-dihtoroxyphentnl

Also Published As

Publication number Publication date
ES413639A1 (es) 1976-01-16
NL174459B (nl) 1984-01-16
IL42016A (en) 1976-05-31
YU37113B (en) 1984-08-31
ZA732136B (en) 1974-03-27
HU167597B (cg-RX-API-DMAC7.html) 1975-11-28
YU97673A (en) 1982-02-25
KR790000113B1 (en) 1979-03-20
KE2870A (en) 1978-09-01
RO65105A (ro) 1980-01-15
SE399064B (sv) 1978-01-30
SU496719A3 (ru) 1975-12-25
PL90695B1 (cg-RX-API-DMAC7.html) 1977-01-31
FR2182947B1 (cg-RX-API-DMAC7.html) 1976-07-02
JPS6221343B2 (cg-RX-API-DMAC7.html) 1987-05-12
RO70892A (ro) 1982-02-26
AU5438573A (en) 1974-10-17
IE37511B1 (en) 1977-08-03
NL174459C (nl) 1984-06-18
PL94207B1 (cg-RX-API-DMAC7.html) 1977-07-30
BE798051A (fr) 1973-10-11
DK142750C (da) 1981-08-17
CS190406B2 (en) 1979-05-31
CY963A (en) 1978-12-22
DD107670B3 (de) 1988-04-06
PH11041A (en) 1977-10-25
AU472734B2 (en) 1976-06-03
YU36483B (en) 1984-02-29
BG23001A3 (bg) 1977-05-20
MY7800381A (en) 1978-12-31
CH569691A5 (cg-RX-API-DMAC7.html) 1975-11-28
HK50178A (en) 1978-09-15
CS190448B2 (en) 1979-05-31
JPS58131945A (ja) 1983-08-06
JPS497237A (cg-RX-API-DMAC7.html) 1974-01-22
YU321279A (en) 1983-04-27
CA1018188A (en) 1977-09-27
HU166213B (cg-RX-API-DMAC7.html) 1975-02-28
DE2317710C2 (de) 1983-08-04
IL42016A0 (en) 1973-06-29
AT323719B (de) 1975-07-25
AR203822A1 (es) 1975-10-31
GB1392674A (en) 1975-04-30
DD107670A5 (de) 1974-08-12
DE2317710A1 (de) 1973-10-18
CH580563A5 (cg-RX-API-DMAC7.html) 1976-10-15
DK142750B (da) 1981-01-12
FR2182947A1 (cg-RX-API-DMAC7.html) 1973-12-14
JPS5825656B2 (ja) 1983-05-28

Similar Documents

Publication Publication Date Title
FR2182947B1 (cg-RX-API-DMAC7.html)
FR2186600A1 (cg-RX-API-DMAC7.html)
FR2177329A5 (cg-RX-API-DMAC7.html)
JPS5214393Y2 (cg-RX-API-DMAC7.html)
JPS499382Y1 (cg-RX-API-DMAC7.html)
JPS49550U (cg-RX-API-DMAC7.html)
JPS4917629U (cg-RX-API-DMAC7.html)
JPS5325766Y2 (cg-RX-API-DMAC7.html)
CS156805B1 (cg-RX-API-DMAC7.html)
JPS4886592U (cg-RX-API-DMAC7.html)
JPS5046693A (cg-RX-API-DMAC7.html)
JPS4898339U (cg-RX-API-DMAC7.html)
CH572344A5 (cg-RX-API-DMAC7.html)
CH568313A5 (cg-RX-API-DMAC7.html)
CH566534A5 (cg-RX-API-DMAC7.html)
CH569955A5 (cg-RX-API-DMAC7.html)
AU480295A (cg-RX-API-DMAC7.html)
CH569204A5 (cg-RX-API-DMAC7.html)
CH575128A5 (cg-RX-API-DMAC7.html)
CH603574A5 (cg-RX-API-DMAC7.html)
CH568120A5 (cg-RX-API-DMAC7.html)
CH587602A5 (cg-RX-API-DMAC7.html)
CH569197A5 (cg-RX-API-DMAC7.html)
CH574977A5 (cg-RX-API-DMAC7.html)
CH566258A5 (cg-RX-API-DMAC7.html)

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
BK Erratum

Free format text: CORRECTION TO PAMPHLET

V4 Discontinued because of reaching the maximum lifetime of a patent